Theravance Biopharma (TBPH) Equity Income (2018 - 2022)
Theravance Biopharma's Equity Income came in at $28.13 million for Q2 2022, up 28.3% from $21.93 million a year earlier and up 12.0% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Equity Income (2018 - 2022) Analysis & Trends
Over the trailing twelve months to Jun 30, 2022, Theravance Biopharma reported Equity Income of $118.75 million, up 64.9% year-over-year; for FY2021, it came in at $103.99 million, up 51.9% from FY2020.
- Equity Income has increased in each of the last three years, with a four-year compound annual growth rate of 397.3% (FY2017 to FY2021).
- Going back by year, Equity Income was $68.44 million in FY2020 (+103.0%), $33.71 million in FY2019 (+201.4%), $11.18 million in FY2018 and $170,000 in FY2017.
- The five-year range for quarterly Equity Income is $686,000 (Q1 2018) to $35.31 million (Q4 2021).
- Year-over-year, Equity Income has increased for 14 consecutive quarters, with growth averaging 57.6% over the last eight quarters.
- Over the past five years, the year-over-year growth in Equity Income ranged from 2.5% (Q2 2021) to 808.0% (Q1 2019).
- Business Quant data shows TBPH's Equity Income at $25.11 million (Q1 2022), $35.31 million (Q4 2021) and $30.21 million (Q3 2021) in the three quarters before Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -10.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 28.13 Mn |
| Mar 31, 2022 | 25.11 Mn |
| Dec 31, 2021 | 35.31 Mn |
| Sep 30, 2021 | 30.21 Mn |
| Jun 30, 2021 | 21.93 Mn |
| Mar 31, 2021 | 16.55 Mn |
| Dec 31, 2020 | 20.14 Mn |
| Sep 30, 2020 | 13.40 Mn |
| Jun 30, 2020 | 21.38 Mn |
| Mar 31, 2020 | 13.52 Mn |
| Dec 31, 2019 | 11.91 Mn |
| Sep 30, 2019 | 7.20 Mn |
| Jun 30, 2019 | 8.37 Mn |
| Mar 31, 2019 | 6.23 Mn |
| Dec 31, 2018 | 5.43 Mn |
| Sep 30, 2018 | 3.12 Mn |
| Jun 30, 2018 | 1.95 Mn |
| Mar 31, 2018 | 686,000.00 |
API Access
Theravance Biopharma Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();